Abstract: Over the past several years, research has indicated that an individual's genetic makeup strongly influences not only their likelihood of developing depression, but also whether or not they will respond well to a particular antidepressant treatment. Identifying those genes regulating susceptibility to depression will increase our understanding of disease pathophysiology and direct the development of treatments that correct underlying neurobiological pathology related to stress-related psychiatric illnesses. Pharmacologically, the identification of genes regulating treatment response can lead to the design of novel pharmacological treatments and allow for more individualized, rational and successful drug treatments. Unfortunately, complex environmental and genetic mechanisms at play in depression and drug response make the discovery of susceptibility genes in humans quite difficult. Animal models may provide a more desirable system in which to discover susceptibility genes because environmental factors and tests can be regulated and more informative genetic methods can be used. Furthermore, a unique genetic opportunity exists with animal models of depression and antidepressant response because several rodent strains have been identified, or selectively bred, that display exaggerated depressive phenotypes on stress-related behavioral tests or divergent responses to antidepressant drugs. This paper reviews several of these rodent strains and illustrates the genetic strategies available to discover the long-sought susceptibility genes regulating these phenotypes.
INTRODUCTION
Depression is a serious and life-threatening disorder of mood resulting from complex genetic and environmental interactions. Twin, family and adoption studies have indicated that an individual's risk of developing depression is strongly influenced by their genetic makeup [1] . Individuals with a first degree relative who has a history of depression are three-times more likely to develop depression than those without one [2] . Although antidepressant drugs can be expected to effectively treat most cases of depression eventually, only approximately 60% of patients demonstrate a favorable treatment response to initial therapy with any type of antidepressant drug [3] . However, if the antidepressant response itself is heritable, a substantial component of treatment failures may be due to some combination of genetically predisposing characteristics. Similar patterns of response (or resistance) to the same antidepressant drug have been observed in families [4, 5] . Furthermore, several human pharmacogenetic studies have recently found positive associations between particular genetic polymorphisms and treatment response to antidepressants (for review see [6] ). For example, a polymorphism in the promoter region of the gene coding for the serotonin transporter has been associated with the efficacy and time of onset of SSRIs [7] [8] [9] [10] [11] [12] and more recently with susceptibility to developing depression itself [13] .
The identification of additional genes influencing risk of depression and predictive of antidepressant response will *Address correspondence to this author at the University of Pennsylvania, Department of Psychiatry, 538 Clinical Research Building, 415 Curie Blvd., Philadelphia, PA 19104; Tel: (215) 573-3305; Fax: (215) 573-2149; E-mail: lucki@pharm.med.upenn.edu improve the diagnosis and drug treatment of clinical depression. A list of candidate genes can be generated from the known pharmacology of antidepressant drugs and stress neurobiology. However, the longest such list would comprise only a small fraction of the thousands of genes with potential impact on depression and makes exclusive suppositions from the perspective of our present knowledge of stress neurobiology, which is likely quite limited. Animal models of depression and antidepressant response have a great deal to offer the geneticist searching for candidate genes for human genetics studies. The identification of candidate genes using animal models can employ techniques that are neutral of prevailing hypotheses regarding human disorders or treatment and are not necessarily limited by prevailing assumptions or knowledge. The literature presents numerous examples of genetically defined inbred rodent strains that show either divergent depressive behavior or divergent responses to pharmacologically selective antidepressants. These strains were either selectively bred for the altered phenotype or identified from a survey of several inbred rodent strains. Before summarizing the literature collected with these strains, we first introduce the primary behavioral tests used to characterize these lines.
RODENT TESTS OF DEPRESSION AND ANTI-DEPRESSANT ACTIVITY
The forced swim test (FST) is the most widely used pharmacological model for screening antidepressant activity. The test consists of placing a rodent (either a rat or mouse) in a cylinder of water from which there is no escape and measuring the animal's activity for several minutes [14] [15] [16] . Rodents engage initially in escape-oriented behaviors (active swimming or climbing the walls of the tank), and that behavior changes eventually into movements that are just sufficient to keep its head above water, termed immobility. Treatment with an antidepressant drug for some time before the test reduces the amount of time spent immobile. Behavioral immobility on this test was initially interpreted as behavioral despair, such that the animal has lost the motivation to perform escape-oriented behaviors due to repeated failures [14] . More recent interpretations [17] view activity and immobility in the FST as alternately active and passive response components of stress withdrawal. When this test is performed with rats, a modified scoring system has been developed that allows one to distinguish serotonergic and noradrenergic antidepressants based on different active behaviors [18] . The FST is sensitive to all major classes of antidepressants, including tricyclics, selective norepinephrine and serotonin reuptake inhibitors, monoamine oxidase inhibitors and atypical antidepressants [19] [20] [21] [22] [23] [24] [25] [26] [27] . On the other hand, exposure to chronic stress, diabetes or other conditions that facilitate depression increase behavioral immobility [28, 29] . The bi-directional sensitivity increases support for the idea that the FST shares some common response features with human depression, although it is not a model of depression itself.
In the tail suspension test [30] , mice are suspended by the tail from an elevated bar for several minutes. Typically, they immediately engage in several escape-oriented behaviors, followed temporally by increasing bouts of immobility. The onset of behavioral immobility is delayed or prevented by antidepressant treatment. The TST has been shown to be sensitive to an array of antidepressants, including tricyclics, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, atypical antidepressants and electroconvulsive therapy [30] [31] [32] [33] [34] . Locomotor activity tests are often used to distinguish antidepressants unambiguously from general psychomotor stimulants in the FST and TST, because most antidepressants suppress immobility even while they reduce locomotor activity of rodents under nonstressful circumstances.
The FST and TST are tests of stress-induced behavioral depression in rodents and are differentially sensitive to antidepressants and to stress-provocative events. These tests do not try to model the complex clinical syndrome of depression and are not models of depression. Rather, the tests isolate simple, quantifiable endophenotypes or response elements that are sensitive to stress and antidepressant action and amenable to biological analysis. The endophenotype concept in psychiatry suggests that complex psychiatric syndromes can be deconstructed into simpler phenotypes, each with a simpler genetic structure than the disease entity taken as a whole [35] . Endophenotypes may be neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive or neuropsychological in nature and can often be modeled in laboratory animals. For example, many schizophenics show sensorimotor gating deficits and this phenotype can be modeled in laboratory animals and shows sensitivity toward antipsychotic medications used in human patients [36] . The use of objective endophenotypes can facilitate the discovery of biological response elements associated with individual components of a more complex disorder.
Another model of stress-induced behavioral depression is the development of learned helplessness (LH). Repeated exposure to a stressful stimulus (i.e., repeated foot shock) that is inescapable leads to the development of learned helplessness [37] . Learned helplessness is usually defined operationally as a failure to exhibit escape behavior during subsequent exposure to the stressful stimulus when escape is possible. The development of learned helplessness is associated with deficits in affect, cognition, and motor responsiveness and may produce other behavioral deficits similar to some symptoms associated with clinical depression [38] . Learned helplessness can be prevented or reversed by antidepressants [39] [40] [41] [42] , supporting its position as an animal model of behavioral depression [43] .
The TST, FST and LH paradigms measure endophenotypes sensitive to clinically effective antidepressants and are excellent candidates for genetic analysis, especially because a number of inbred strains with extreme phenotypes on these tests have been developed, as discussed below. Table 1 summarizes a number of rat and mouse strains that show characteristic performance differences on a number of different tests measuring stress-induced behavioral depression that have been characterized as exaggerated depressive-like behavior. Also included in Table 1 are rat and mouse strains that demonstrate divergent responses (resistance versus vulnerability) to different types of pharmacologically selective antidepressants on similar tests. The table is organized first by the behavioral characteristic tested (behavioral depression or antidepressant response) and then by rodent species (rat or mouse). If the rodent strain is inbred as a result of selective breeding, the outbred strain from which they were derived is listed. Finally, the behavioral phenotypes of the strain are briefly summarized and reference is given to the primary literature.
PHENOTYPICALLY-DEFINED INBRED STRAINS

RAT STRAINS SHOWING EXAGGERATED STRESS-INDUCED BEHAVIORAL DEPRESSION
The Flinders Line rats are perhaps the most thoroughly characterized genetic animal model of depression [44] . They were developed at Flinders University in Australia by selective breeding of outbred Sprague Dawley rats for differences in the effects of the anticholinesterase, diisopropylfluorophosphate (DFP) on temperature, drinking and body weight. The Flinders Sensitive Line (FSL) rats are more sensitive to DFP and cholinergic agonists than Flinders Resistant Line (FRL) rats, which serve as controls for the FSL rats. Depressed humans show elevated sensitivity to cholinergic agonists [45] , which led to the original proposal of the FSL rats as an animal model of depression [46] .
A large body of behavioral, neurochemical and pharmacological literature supports the claim that FSL rats are an animal model of depression. On the behavioral end, FSL rats show decreased bar pressing for water [47] or food [48] reward than FRL rats, mimicking the decreased pleasureseeking behavior, or anhedonia, seen in depressed humans. FSL rats also demonstrate "depressive-like" pattern of avoidance behaviors, by showing a decreased tendency to actively avoid an aversive stimulus [49] such as footshock and an increased tendency toward passive avoidance [50] . Furthermore, FSL rats display exaggerated immobility in the forced swim test (FST). In the classical FST [14] [15] [16] , rats are exposed to a 15-minute forced swim session 24 hours before the actual 5-minute test, in part, to facilitate the development of behavioral immobility. However, FSL rats show high levels of immobility in the first 5 minutes of their initial test without such a pre-swim, and demonstrate twice the values of immobility as FRL rats. In addition, FSL rats subjected to chronic mild stress demonstrate a greater decrease in saccharin preference [51] , suggesting enhanced vulnerability to the anhedonic effects of stress. Furthermore, the elevated FST immobility displayed by FSL rats is reduced by chonic treatment with a number of antidepressant drugs, including the tricyclics imipramine [52] and desipramine [51] and the selective serotonin reuptake inhibitor sertraline [51] . FSL rats also mimic depressed humans in showing greater REM sleep and a shorter interval between REM episodes than FRL rats [53] [54] [55] . These differences occur in the basal state and, unlike the above-mentioned behavioral differences, do not require exposure to stressful conditions. There is a substantial co-morbidity between depression and anxiety and many antidepressants are effective anxiolytics. So it was of interest to determine if FSL rats could model enhanced depression and anxiety. Notably, the FSL rats do not differ from the FRL rats in the elevated plus maze, a well-accepted test for anxiety [56] . The Flinders lines also failed to show differences after injection of the typical anxiolytic diazepam [57] . Therefore, FSL rats appear to show behavioral specificity as an animal model of depression, without a significant anxiety component.
A number of studies have attempted to understand the neurochemical differences between FSL and FRL rats that underlie their interesting behavioral differences. Although these lines were selected for divergent effects of an anticholinestrase, not all behavioral features of FSL rats can be accounted for by differences in cholinergic function (reviewed in [58] ). For example, when FSL and FRL rats were crossbred to produce F1, F2 and backcross progeny, the immobility time in the forced swim test did not correlate with the hypothermic response to an anticholinesterase, but rather correlated with the hypothermic response to 8-OH-DPAT, a 5-HT 1A receptor agonist [59] . There have since been numerous reports of serotonergic dysfunction in FSL rats (reviewed in [58] ), including increased tissue levels of 5-HT and 5-HIAA, which can be normalized by chronic antidepressant treatment [60] .
To our knowledge, no genetic linkage studies have been performed with the Flinders Line rats despite the fact that they provide an excellent opportunity to map genes regulating susceptibility to depression. In the course of selective breeding, the FSL rats presumably inherited genetic variants predisposing to a depressed phenotype, while FRL rats inherited other genetic variants protective against this phenotype. As mentioned above, Overstreet and colleagues have crossed FSL and FRL rats to produce F1, F2 and backcross progeny [46] and tested these animals for FST immobility.
The immobility values of the segregating populations tended to be intermediate between the parental lines suggesting predominantly additive genetics. While this study stopped short of performing genetic linkage, it showed the genetic basis for behavioral differences between FSL and FRL rats. As described in the next section, a quantitative trait loci study could identify the approximate chromosomal position of genes regulating differences between FSL and FRL rats.
The Wistar Kyoto (WKY) rat has been proposed as an animal model of depressive behavior because it consistently demonstrates exaggerated behavioral and physiological responses to stress across a variety of situations in comparison to other strains [61, 62] . The WKY line was initially bred from outbred Wistar rats as the control strain for the spontaneously hypertensive rat [63] . Compared to other strains such as inbred Fisher 344 or outbred Sprague Dawley rats, WKY has elevated FST immobility [64] [65] [66] , high susceptibility to learned helplessness [64, 67] , high emotionality and freezing behavior in response to stress [68] and decreased exploratory activity in the open field [69, 70] . Furthermore, WKY rats secrete greater levels of stress hormones in response to forced swimming [71] and restraint or cold stress [61] and are very susceptible to gastric ulceration [64, 72] . Using quantitative trait loci (QTL) analysis (see next section and Fig. (1) ) in the segregating F2 generation of a WKY x Fisher 344 cross [73] , Redei and colleagues [74] identified multiple QTL for depressive behavior in the forced swim test and the plasma corticosterone response to restraint stress. None of the identified QTL for behavioral despair and stress corticosterone were similar, supporting an earlier finding that separate genetic pathways are involved in behavioral stress and endocrine responsiveness in this intercross [73] . This discovery of rat chromosomal loci regulating depressive behavior in the FST [74] illustrates the utility of the QTL approach and has directly nominated the syntenic regions of the human genome for containing depression susceptibility genes.
Weiss and colleagues selectively bred Sprague-Dawley rats to produce rats with either high or low motor activity in a modified forced swim test [75] . In a 15-minute swim test, Swim Low-Active (SwLo) rats show little struggling and much floating, while Swim High-Active (SwHi) rats show the reverse. Further experiments showed that these strains do not differ in daily spontaneous locomotor activity, but do show activity differences in response to acute challenges such as those encountered in the open field, novel home cage and Porsolt-type swim test. Under these conditions, SwHi rats show more active behavior, whereas SwLo rats show a deficit of this response [75] . These lines have also been tested with various classes of antidepressants in the forced swim test. The results showed that chronic but not acute treatment with norepinephrine reuptake inhibitors and MAOIs could increase the activity of SwLo rats, but an SSRI was ineffective. No antidepressants were active in the SwHi rats [76] .
The Fawn-Hooded (FH/Wjd) rat is an inbred strain that shows hypercortisolemia [77] and altered responses to serotonergic drugs [78, 79] . In addition, FH/Wjd rats demonstrate high FST immobility and high voluntary ethanol intake [79, 80] compared to other strains, such as the inbred ACI/N rats. Recently, Overstreet and colleagues [81] have intercrossed FH/Wjd and ACI/N rats to produce F1 and F2 progeny and tested them for immobility and alcohol intake. These two phenotypes were distributed in different patterns in the F1 and F2 mice, suggesting that they under separate genetic regulation.
5-HT 1A receptors have been implicated in the etiology of anxiety and depression because 5-HT 1A receptor agonists, such as 8-hydroxydipropylaminotetralin (8-OH-DPAT) and buspirone, have anxiolytic and antidepressant effects and suicide victims show altered expression of 5-HT1A receptors [82, 83] . One functional response of 5-HT 1A receptors in rats is the regulation of core body temperature, such that systemic administration of 8-OH-DPAT will reduce a rat's body temperature. Overstreet and colleagues created two lines of rats with differential sensitivity to 8-OH-DPATinduced hypothermia. Rats of the HDS (high DPAT sensitivity) line are more sensitive to the hypothermic effects of 8-OH-DPAT (0.5 mg/kg, IP) than are rats of the LDS (low DPAT sensitivity) line [84, 85] . HDS rats also exhibit elevated baseline immobility in the forced swim test [85] , agreeing well with a previously mentioned study where high FST immobility correlated with increased hypothermic response to 8-OH-DPAT in a FSL x FRL cross [59] . Because they differ in both baseline FST immobility and 8-OH-DPAT sensitivity, the HDS and LDS strains could be used to map genes regulating behavioral depression and drug response, perhaps in the same segregating F2 population.
HDS and LDS rats display similar baseline behavior in the elevated plus maze, but HDS rats show an anxiety-like profile (low social interaction) in the social interaction test [85] [86] [87] . Other groups have also seen a lack of agreement between these two tests using other rat strains [88, 89] , so the authors utilized a third anxiety test, the conflict task. The HDS rats exhibited less response under punished conditions, suggesting anxiety-like behavior [90] . Therefore, although further examination is required, the HDS rat may ultimately be considered an animal model of co-morbid depression and anxiety.
HDS rats have elevated 5-HT 1A receptor binding in the limbic cortical regions, but not in the median or dorsal raphe nuclei, where 5-HT cell bodies are located, the hypothalamus where hypothermic responses may be mediated, or the hippocampus where anxiety-like responses can be induced [91] . Therefore, it is not clear whether the increase of receptors in HDS rats are related to their increased sensitivity to 8-OH-DPAT or to their behavioral disturbances. To address this question, 8-OH-DPAT was administered directly into the hippocampus, and the LDS rats showed an anxiety-like response (lower social interaction), but the HDS rats did not [86, 87] . Furthermore, reduced social interaction in the HDS rats could not be counteracted by chronic fluoxetine, even though this treatment is sufficient to blunt hypothermic responses to 8-OH-DPAT [86, 92] . Thus, the behavioral differences between the HDS and LDS rats cannot be accounted for by simple differences in density of 5-HT1A receptors [91, 93] . Functional coupling of the 5-HT 1A receptor to its downstream effectors was then measured in HDS and LDS rats, by examining GTPγS binding under basal conditions and after incubation of brain tissues with 8-OH-DPAT [93] . There were no differences in any brain region between the HDS and LDS rats under either basal or 8-OH-DPAT-stimulated conditions [93] . Therefore, the issue of which changes in 5-HT 1A receptor function, if any, are responsible for the differential hypothermic and behavioral responses of HDS and LDS rats remains unresolved.
Henn and Edwards [94] have selectively bred Sprague Dawley (SD) rats with high and low propensities to develop learned helplessness (LH). Congenitally learned helpless (cLH) rats show pronounced LH, while congenitally non-learned helpless (cNLH) animals are highly resistant to LH. Congenitally learned helpless animals have an abnormal stress response, including altered HPA axis responsiveness [95] [96] [97] , increase in pain tolerance and decrease in spatial cognitive performance after exposure to stress [98] , altered serotonin autoreceptor (5-HT 1B ) regulation [99] , and changes of induction of glucocorticoid mRNA in the limbic system [100] . These helpless rats have also been described as showing other behaviors that might simulate symptoms in depressed humans, including decreased locomotion, loss of appetite and weight, reduced dominance and sex drive, and altered sleep [94] . To our knowledge, no breeding or genetic mapping studies have been performed with the cLH or cNLH rat lines.
MOUSE STRAINS SHOWING EXAGGERATED STRESS-INDUCED BEHAVIORAL DEPRESSION
Vaugeois and colleagues have selectively bred CD-1 mice for high and low immobility on the tail suspension test [101] and recently performed a very thorough behavioral, neurochemical and electrophysiological characterization of these lines [102] . After 8 generations of breeding, helpless (HL) mice spent about 200 seconds immobile in a 6-minute tail suspension test, while non-helpless mice (NHL) spent fewer than 10 seconds immobile [102] . This difference extended to the mouse forced swim test, where HL mice showed 2-3 times greater immobility than NHL mice. Several other features of the HL line were given as supporting a more general role for these mice as a genetic mouse model of depression. HL mice respond to both noradrenergic and serotonergic antidepressants in the TST and FST. HL mice have elevated basal levels of corticosterone and show reduced consumption of a palatable 2% sucrose solution. HL mice have higher 5-HT levels in the prefrontal cortex and hippocampus, which is accompanied by decreased 5-HT turnover and increased densities of the 5-HT transporter in motor cortex [102] . Further abnormalities of the 5-HT system suggestive of human depression were noted in the form of supersensitive 5-HT 1A receptors and the differential ability of chronic treatment with fluoxetine to down-regulate 5-HT 1A receptors in HL, but not NHL mice [102] . These mouse lines are excellent candidates for genetic analysis and will likely lead to the identification of genes regulating behavioral despair in mice. To our knowledge, no genetic mapping studies using these lines are in progress.
Other mouse lines showing abnormal FST or TST immobility have been discovered by surveying several commercially-available inbred mouse strains. Yoshikawa et al. [103] tested four inbred mouse strains and found that C57BL/6J mice demonstrate higher TST and FST immobility than C3H/He mice. They intercrossed these lines to produce F1 and F2 animals and tested them for TST and FST immobility. These progeny showed immobility values intermediate of the parents, but little correlation was seen between FST and TST immobility values for individual animals, suggesting separate genetic determinants for these two tests of stress-induced behavioral depression [103] . The authors successfully mapped several QTL regulating immobility in the segregating F2 population, including loci on chromosomes 8 and 11 which overlap between the two behavioral measures [103] . Two of the QTL involved in TST immobility contain genes encoding GABA A receptor subunits, and the authors noted decreased alpha1 subunit mRNA expression in the frontal cortex of C57BL/6 mice compared to C3H/He mice. Additional TST and FST strain surveys have supported the immobility differences between C57BL/6 and C3H/He mice [104] [105] [106] and have also found that the FVB strain has very low FST immobility [105] .
Shanks and Anisman [107] examined learned helpless behavior induced by inescapable shock in six strains of mice. Animals were exposed to inescapable footshock followed immediately or 24 hours later by shuttle-escape testing, in which their latency to escape shock from an electrified floor was measured. In this paradigm, some strains showed pronounced escape deficits (BALB/c and C57BL/6) indicating learned helpless behavior, whereas in other strains the deficits were smaller (A/J) or entirely absent (DBA/2). In a follow-up study [108] , the authors measured alterations in the levels of monoamine neurotransmitters following inescapable footshock in different brain regions in the same six strains. In every strain tested, stress reduced hypothalamic norepinephrine and increased the norepinephrine metabolite MHPG. In contrast, the effects of the stressor on norepinephrine activity in the hippocampus and locus ceruleus varied across strains, but did not correlate with strain differences in learned helplessness. Likewise, concentrations of dopamine and its metabolite DOPAC measured in the ventral tegmental area, nucleus accumbens and frontal cortex, and concentrations of serotonin and its metabolite 5-HIAA measured in the hypothalamus, hippocampus and frontal cortex, also differed by strain, but did not correlate with stressor-induced behavioral differences.
RAT STRAINS SHOWING ALTERED ANTIDEPRES-SANT RESPONSE
As Table 1 illustrates, more strains have been identified with altered behavioral depression than altered response to antidepressant drugs. This probably reflects the additional resources, time and controls that need to be included to identify such strains, rather than a lack of genetic diversity regulating antidepressant response in rodents. The only rat strains selectively bred to show altered antidepressant/ anxiolytic responses are the high and low DPAT sensitive strains discussed above [84, 85] , although these strains distinguished reponse to a target (5-HT 1A receptors) rather than to an established drug. Not much is known about the sensitivity of these strains to other antidepressants and to our knowledge they have not been the subject of a genetic study concerning drug responses.
Rat strain surveys have identified inbred strains with differential sensitivities to pharmacologically diverse antidepressants in the forced swim test. Lahmame and Armario [109] studied the effects of acute desipramine and 8-OH-DPAT on five inbred rat strains in the forced swimming test. The strains were Brown-Norway (BN), Fischer 344 (FIS), Lewis (LEW), Spontaneously Hypertensive Rats (SHR) and Wistar-Kyoto (WKY). In the FST, desipramine increased struggling and reduced immobility in BN, FIS and LEW rats, but did not exert any effect in SHR and WKY rats [109] . In addition, WKY rats were uniquely nonresponsive to two doses of 8-OH-DPAT. The authors concluded that WKY rats are not only passive in the FST, but are also subsensitive to acute antidepressant administration.
In a follow up study, Lahmame et al. [110] studied whether or not WKY rats respond in the FST to acute and chronic administration of imipramine. Sprague-Dawley and Brown-Norway rats were included because these two strains responded to acute desipramine and 8-OH-DPAT treatment [109] . Acute administration of imipramine significantly increased struggling and reduced immobility in SpragueDawley and Brown Norway rats, but Wistar-Kyoto rats failed to respond to the drug. After chronic imipramine, all three strains showed a significant response, but the effect in WKY was much lower than in the other two strains. Summarizing both studies by Lahmame et al., WKY rats seemed to demonstrate low sensitivity both noradrenergic (desipramine and imipramine) and serotonergic (8-OH-DPAT) antidepressants.
In a subsequent study, Lopez-Rubalcava and Lucki [66] examined differences in the behavioral response to different types of antidepressant drugs between WKY and SpragueDawley (SD) rats in the modified-forced swimming test [18] . As expected, WKY rats displayed significantly greater immobility than SD rats during their exposure to the FST. The noradrenergic antidepressant, desipramine, produced a dose-dependent reduction of immobility and increase of climbing behavior in the SD rats when given subchronically (3 injections within 24 hours). In WKY rats, desipramine actually reduced immobility at a lower dose and produced increases of both swimming and climbing behavior. This result is at odds with those of Lahmame and Armario [109] , but may be due to different testing conditions and scoring criteria used in these studies. Lopez-Rubalcava and Lucki [66] measured climbing behavior, known to be induced by noradrenergic antidepressants such as desipramine [18] , while Lahmame and Armario [109] did not. The serotonergic compounds, fluoxetine and 8-OH-DPAT, produced dosedependent reductions of immobility and increases of swimming behavior in the FST in SD rats, but the response to the serotonergic drugs were blunted in WKY rats, agreeing well with Lahmame et al. [109, 110] .
Tejani-Butt et al. [111] measured the effects of repeated antidepressant drug treatment on FST behavior in Wistar Kyoto (WKY), outbred Wistar and Sprague-Dawley (SD) rats. Rats were treated with desipramine, nomifensine, paroxetine or saline for 11 days prior to the Porsolt forced swim test. WKY rats again showed excess immobility in the FST as compared to Wistar and SD rats. The noradrenergic antidepressants desipramine and nomifensine, but not the serotonergic antidepressant paroxetine, decreased immobility and increased swim time in the FST in WKY rats. Surprisingly, none of the drugs altered FST behavior in SD rats. These results nonetheless provide further evidence for a lack of sensitivity to serotonergic antidepressants, but responsiveness to noradrenergic antidepressants, in the WKY strain.
Evidence in the literature [112] has suggested that the WKY strain possesses greater behavioral and genetic heterogeneity than other inbred strains. Will et al. [113] took advantage of this variability by selectively breeding WKY rats with altered immobility in the forced swim test (FST). Successive generations of selective breeding resulted in rats with extremes of immobility in the FST: 'WKY most immobile' (WMI) and 'WKY least immobile' (WLI). Subacute treatment of males with several classes of antidepressant had different effects on FST behavior in the two substrains. Both desipramine, a noradrenergic antidepressant, and phenelzine, a monoamine oxidase inhibitor, significantly and drastically decreased FST immobility in WMI. In contrast, WLI showed a limited response to these antidepressants. Neither substrain responded to the selective serotonin reuptake inhibitor fluoxetine, strengthening the case for diminished sensitivity to serotonergic antidepressants in WKY rats.
MOUSE STRAINS SHOWING ALTERED ANTIDE-PRESSANT RESPONSE
Several studies have surveyed inbred mouse strains for differences in antidepressant sensitivity on the TST, FST and LH paradigms. Three strain surveys using the tail suspension test (TST) have been performed. The first [114] measured the effects of imipramine in reducing immobility among 11 inbred strains of mice. Significant strain differences in immobility duration were found for both basal TST and in the treatment response to imipramine (30 mg/kg i.p.) with heritability estimates of .31 and .60, respectively, derived from the comparison of within-strain and between-strain variability. Immobility duration for the DBA/2J, FVB/NJ, and NMRI strains were significantly reduced by imipramine, relative to saline. This reduction of immobility by imipramine was independent of the basal immobility, suggesting that these responses are mediated by separate genetic pathways.
A second TST strain survey was performed by Ripoll et al. [115] . In this study four mouse strains (Swiss and NMRI, two outbred strains and DBA/2 and C57BL/6J Rj, two inbred strains) were tested in the TST after acute administration of five antidepressants: the tricyclic antidepressants imipramine and desipramine, the selective serotonin reuptake inhibitors paroxetine and citalopram and the dopamine reuptake inhibitor buproprion. The C57BL/6J Rj strain had a longer baseline immobility time in comparison to the other strains. All antidepressants included in this study significantly decreased immobility in the outbred Swiss and inbred C57BL/6J Rj strains. In addition, the size-effect of desipramine, paroxetine and bupropion was greater in Swiss mice than any other strain. The NMRI and DBA/2 mice only responded to paroxetine, citalopram and imipramine. These results provide further evidence of marked strain differences in the response to different types of antidepressants.
A third TST strain survey [106] compared behavioral baselines and examined dose-response curves to the SSRI citalopram in 8 inbred mouse strains. The DBA2/J, BALB/cJ and BTBR strains were most sensitive to the effects of citalopram, while citalopram was least effective in the C57BL/6J and A/J strains. This pattern agrees with a mouse strain survey that examined sensitivity to fluoxetine in the forced swim test (see below; [105] ). The antidepressant-like effects of citalopram in the TST were not correlated with changes in locomotor activity across the individual mouse strains. Furthermore, robust inhibition of deprivationinduced feeding behavior was shown by citalopram in the two strains most sensitive (BTBR, BALB/cJ) and the two strains least sensitive in the TST (A/J and C57BL/6J). This indicates that patterns of sensitivity to citalopram across strains are behaviorally specific and that the insensitivity of A/J and C57BL/6J mice in the TST is unlikely to result from pharmacokinetic variables since citalopram potently produces other behavioral effects. In conclusion, three tail suspension test strain surveys have revealed genetic differences between inbred strains regulating antidepressant response and have suggested appropriate strains for performing genetic mapping studies.
The mouse forced swim test has been the focus of three strain surveys of antidepressant activity. In the first, Porsolt et al. [16] treated CD, NMRI and OF-1 mice with various doses of imipramine and all three strains responded with dose-dependent reductions of immobility. In the second study, Lucki et al. [105] measured responses to desipramine, a selective norepinephrine reuptake inhibitor, and fluoxetine, a selective serotonin reuptake inhibitor, in seven inbred and four outbred mouse strains in the forced swimming test. In general, inbred strains demonstrated lower variability than outbred strains, suggesting genetic influence. Desipramine dose-dependently reduced immobility in seven of the 11 strains tested, with DBA/2J and the C57BL/6J mice showing greater sensitivity than the other strains. In contrast, fluoxetine reduced immobility in only three out of the 11 strains tested, DBA/2J, BALB/cJ and NIH Swiss mice, demonstrating a marked contrast in the pattern between the two antidepressants.
In a third FST strain survey, David et al. [116] tested five antidepressants (imipramine, desipramine, citalopram, paroxetine and bupropion) in two outbred strains (Swiss, NMRI) and two inbred strains (DBA/2, C57BL/6J Rj). Imipramine, desipramine, citalopram and paroxetine treatment decreased immobility in Swiss mice. However, the NMRI strain was sensitive only to paroxetine, the C57BL/6J Rj strain was sensitive only to buproprion and DBA/2 mice were insensitive to all antidepressants tested. The results that David et al. [116] obtained for DBA/2, C57BL/6J and NMRI strains are somewhat at odds with the prior studies by Porsolt et al. [16] and Lucki et al. [105] . They may be related partially to differences in methodology. David One strain survey of antidepressant sensitivity in the learned helplessness paradigm was performed by Shanks and Anisman [117] . The acute and chronic effects of several antidepressants (desmethylimipramine, amitriptyline and bupropion) on escape deficits induced by inescapable shock were assessed in four strains of mice. Chronic administration of desmethylimipramine eliminated the escape interference in A/J, but did not affect the performance of BALB/c, C57BL/6 or CD-1 mice; acute treatments were ineffective. Bupropion, in contrast, had a modest effect only in chronically treated CD-1 mice. Finally, the 5-HT reuptake blocker, amitriptyline, was found to influence escape performance in acute and chronically treated A/J and acutely treated BALB/c mice. In summary, background strain is a critical variable in determining baseline performance and sensitivity to different types of antidepressant drugs in mouse tests of antidepressant activity and differences between strains can be the starting point for a genetic study.
MAPPING QUANTITATIVE TRAIT LOCI
Unlike traits that are characterized by an all-or-none type of inheritance (i.e. Huntington's disease), behaviors measuring stress-induced behavioral depression and antidepressant drug responses are both examples of quantitative traits that can be measured continuously on a quantitative scale. Vulnerability to depression and response to drug treatment are likely determined by polygenic contributions that can be measured by graded differences in response on behavioral tests. Quantitative traits are influenced by the environment and the cumulative action of multiple genes, each of which may produce a small to moderate effect. Quantitative trait loci (QTL) are simply chromosomal regions that contain a gene, or genes, that regulate a portion of the genetic variation for a quantitative trait. Identification of QTL can lead to the discovery of individual genes that are related to behavioral responses associated with depression.
Lander and Botstein [118] developed methods allowing the simultaneous mapping of multiple QTLs regulating a portion of the genetic variation for a particular phenotype. These methods utilize high-resolution genetic linkage maps to correlate quantitative phenotypic data in a population with marker genotypes. Most designs start with two inbred parents that differ with respect to the trait of interest, either by chance or selective breeding (see Fig. (1) ). Segregation and recombination is then allowed to introduce genetic variability that is correlated with phenotypic variability to identify areas of chromosomes that are associated with the expression of phenotypic traits. For example, several inbred rodent strains possess widely different phenotypes under a constant environment, suggesting genetic variability and providing a starting point for a QTL analysis. Crossing two divergent strains produces an F1 generation that often possesses a phenotype intermediate of the parents. An F2 population with new arrangements of genes is then derived from a cross of F1 hybrids. The trait of interest is analyzed in a large number of F2 animals and markers polymorphic between the two parent strains are genotyped. Finally, a variety of statistical procedures are then used to test the probability that variation in the phenotype is associated with a particular genetically mapped marker.
Initially, QTLs are localized to very large chromosomal regions (~20 cM) that may contain hundreds of genes. With the completed sequencing of the mouse genome [119] , it is now possible to identify all of the genes within a QTL and nominate candidate genes based on their known or inferred role in a phenotype. Further narrowing of QTL regions can aid in the nomination of candidate genes. A number of strategies for narrowing QTL regions have been proposed [120] with the construction of a congenic strain being the most popular. The final step in QTL analysis is the identification of the gene(s) that contains functional polymorphisms responsible for the phenotypic differences in the parental lines. These polymorphisms might exist in exons and produce amino acid sequence differences in protein, could be located in the promoter or enhancer region and alter transcription or could be intronic and influence mRNA splicing. Recently, a large-scale sequencing effort by Celera Genomics has analyzed genetic sequence differences between five inbred strains of mice (C57BL/6J, DBA/2J, A/J, 129X1/SvJ, 129S1/SvImJ). They have identified and mapped 3.3 million single nucleotide polymorphisms (SNPs) Fig. (1) . QTL mapping. In this design, crossing two divergent strains produces an F1 generation, which is heterozygous for at every position where the parents differed. An F2 population is then derived from a cross of F1 hybrids. The trait of interest is then analyzed in a large number of F2 animals and markers polymorphic between the two parent strains (i.e. A and B) are genotyped. Those marker alleles which are linked to a QTL for a high score on the trait will be overrepresented in the F2 animals with high scores and underrepresented in those animals with low scores.
differing between at least two of these strains. An online database (www.celera.com) allows one to search for polymorphisms in any region of the mouse genome and predict their functional significance in terms of protein coding, transcription factor recognition and alternative splicing. Information of this sort should aid in the identification of SNPs causing QTL.
As a good example of the QTL approach, Yoshikawa et al. [103] mapped QTL regulating baseline behavior on the mouse FST and TST. They found C57BL/6 mice to have high baseline immobility on both the FST and TST, while C3H mice showed much lower immobility. The authors phenotyped and genotyped a total of 560 F2 mice and QTL mapping revealed five major loci affecting immobility in the FST, and four loci for the TST. The quantitative trait loci (QTL) on chromosomes 8 and 11 overlap between the two behavioral measures. Genome-wide interaction analysis, which identifies locus pairs that may contribute epistatically to a phenotype, detected two pairs of chromosomal loci for the TST. The QTL on chromosome 11 and its associated epistatic TST-QTL on chromosome X both encode gammaaminobutyric acid type A (GABA(A)) receptor subunits as candidates. Sequence and expression analyses of these genes from the two parental strains revealed a significantly lower expression of the alpha1 subunit gene in the frontal cortex of C57BL/6 mice compared to C3H mice. These results are especially interesting in light of a human genetic linkage study [121] which detected chromosomal area 5q34 as a susceptibility region for mood disorders. This region of human chromosome 5 is syntenic with the QTL on mouse chromosome 11 and contains GABA(A) receptor subunit genes. Furthermore, polymorphisms in two of these genes (GABRA1 and GABRA6) have displayed significant associations with mood disorders in female patients [122] . These studies provide a good example of how human and rodent behavioral genetics can complement and inform one another.
As mentioned above, our laboratory has measured sensitivity to the SSRI citalopram in 8 inbred mouse strains in the tail suspension test [106] . In this survey, BALB/cJ mice showed a high sensitivity to 20 mg/kg citalopram (~70% decrease in immobility), while A/J mice were largely insensitive (~20% decrease in immobility). More recently, we have crossed BALB/cJ and A/J mice to produce an F1 population of animals and report here that the distribution in sensitivity to citalopram in F1 mice is intermediate that of the parental strains (see Fig. (2) ). This result suggests a strong genetic influence underlying the antidepressant response to an SSRI. This relationship will continue being investigated by breeding and testing the F2 generation and a QTL study for antidepressant response.
Numerous QTL experiments in mice have successfully identified loci regulating several behavioral and pharmacological traits (for review, see [123] ), including learning and memory [124, 125] , anxiety [126] [127] [128] [129] , seizure susceptibility [130] [131] [132] , drug preference [133] [134] [135] [136] [137] and stress-induced behavioral depression (baseline immobility on the FST and TST; [103] ). Utilizing the congenic approach, Ferraro et al. [132] and Fehr et al. [137] were able to substantially narrow QTLs of major effect for seizure susceptibility and alcohol withdrawal, respectively. Although identifying the actual gene(s) underlying QTLs has been slow and difficult, 29 mammalian QTL genes (11 in mice) have now been identified, almost half of them in 2001 [138] . The acceleration in Fig. (2) . Distribution of the TST response to 20 mg/kg citalopram in two inbred strains and their intercross. Distribution of the TST citalopram response is shown for the A/J strain (n= 25), who were not responsive to citalopram, and the BALB/cJ strain (n= 19), who were highly responsive to citalopram. Mice from the F1 generation of the intercross (n= 28) demonstrated intermediate responsiveness between the two parental strains. Mice were tested twice on the TST: once with saline and once with 20 mg/kg citalopram (i.p.) separated by 7 days. Percent decrease in immobility was calculated by dividing the citalopram immobility score by the saline immobility score, multiplying by 100 and subtracting from 100. Mice were injected with drug 30 minutes prior to a 6-minute tail suspension test. QTL gene discovery is being fueled by the availability of the human and mouse genome sequences and the increasing availability of polymorphic markers [138] .
CONCLUSION
Numerous behavioral tests have identified rodent strain differences in behavioral response to tests of stress-induced behavioral depression or in the response to antidepressant drug treatments. Some of the animal models have been characterized in detail as showing numerous behavioral and physiological changes that resemble multiple symptoms of human depression. Such biological differences may provide models for discovering genetic components that regulate biological systems that are homologous with human genetic components of depression. Other studies have demonstrated specific strain differences measured in antidepressant effects on animal tests of stress-induced depression. These strain differences could provide models to identify genes regulating treatment response that would lead to the design of novel pharmacological treatments and allow for more individualized, rational and successful drug treatments for human depression. The development of modern genetic techniques now makes the translation of this information from these traditional animal behavior models to potential application in clinical treatment feasible.
